We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 6,508 results
  1. Validation of an automated sample preparation module directly connected to LC-MS/MS (CLAM-LC-MS/MS system) and comparison with conventional immunoassays for quantitation of tacrolimus and cyclosporin A in a clinical setting

    Background

    Therapeutic drug monitoring (TDM) systems generally use either liquid chromatography/tandem mass spectrometry (LC-MS/MS) or immunoassay,...

    Tsutomu Shimada, Daisuke Kawakami, ... Yoshimichi Sai in Journal of Pharmaceutical Health Care and Sciences
    Article Open access 08 January 2024
  2. Cyclosporin A-loaded dissolving microneedles for dermatitis therapy: Development, characterisation and efficacy in a delayed-type hypersensitivity in vivo model

    Several drugs can be used for treating inflammatory skin pathologies like dermatitis and psoriasis. However, for the management of chronic and...

    Miquel Martínez-Navarrete, Antonio José Guillot, ... Ana Melero in Drug Delivery and Translational Research
    Article Open access 12 March 2024
  3. Intravenous injection of cyclosporin A loaded lipid nanocapsules fights inflammation and immune system activation in a mouse model of diabetic retinopathy

    Inflammation and immune system activation are key pathologic events in the onset and escalation of diabetic retinopathy (DR). Both are driven by...

    Marilena Bohley, Andrea E. Dillinger, ... Achim Goepferich in Drug Delivery and Translational Research
    Article Open access 19 May 2023
  4. Studies on spray dried topical ophthalmic emulsions containing cyclosporin A (0.05% w/w): systematic optimization, in vitro preclinical toxicity and in vivo assessments

    Cyclosporin A (CsA, 0.05% w/w)–loaded positively charged emulsions were prepared based on castor oil, chitosan, poloxamer 188, glycerin and...

    Syed Nazrin Ruhina Rahman, Neha Agarwal, ... Tamilvanan Shunmugaperumal in Drug Delivery and Translational Research
    Article 03 January 2023
  5. Application of Design of Experiments® Approach-Driven Artificial Intelligence and Machine Learning for Systematic Optimization of Reverse Phase High Performance Liquid Chromatography Method to Analyze Simultaneously Two Drugs (Cyclosporin A and Etodolac) in Solution, Human Plasma, Nanocapsules, and Emulsions

    The objectives of current investigation are (1) to find out wavelength of maximum absorbance (λ max ) for combined cyclosporin A and etodolac solution...

    Syed Nazrin Ruhina Rahman, Oly Katari, ... Tamilvanan Shunmugaperumal in AAPS PharmSciTech
    Article 13 May 2021
  6. Prednisolone and rapamycin reduce the plasma cell gene signature and may improve AAV gene therapy in cynomolgus macaques

    Adeno-associated virus (AAV) vector gene therapy is a promising approach to treat rare genetic diseases; however, an ongoing challenge is how to best...

    Alexander Kistner, Jessica A. Chichester, ... Barbara A. Sullivan in Gene Therapy
    Article Open access 13 October 2023
  7. Derivation of metabolic point of departure using high-throughput in vitro metabolomics: investigating the importance of sampling time points on benchmark concentration values in the HepaRG cell line

    Amongst omics technologies, metabolomics should have particular value in regulatory toxicology as the measurement of the molecular phenotype is the...

    Julia M. Malinowska, Taina Palosaari, ... Mark R. Viant in Archives of Toxicology
    Article Open access 22 January 2023
  8. The Pharmacokinetic Prediction of Cyclosporin A after Coadministration with Wuzhi Capsule

    We aim to describe the influence of principal ingredients of Wuzhi capsule, schisandrin A (SIA) and schisantherin A (STA), on the pharmacokinetics of...

    **g**g Fan, Lu Chen, ... Liqin Zhu in AAPS PharmSciTech
    Article 08 July 2019
  9. Cyclosporin A activates human hepatocellular carcinoma (HepG2 cells) proliferation: implication of EGFR-mediated ERK1/2 signaling pathway

    One of the most common causes of cancer mortality worldwide is hepatocellular carcinoma (HCC). Extracellular signal-regulated kinase (ERK1/2) pathway...

    Mohammed E. Abo-El Fetoh, Gouda K. Helal, ... El-Sayed Akool in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 06 January 2020
  10. Systematic Optimization, In Vitro Drug Release, and Preliminary Nonclinical Toxicity Assessment of Nonphospholipid-Based Topical Ophthalmic Emulsions Containing 0.05 or 0.1% w/w Cyclosporin A for Dry-Eye Syndrome Management

    The objectives of the present investigations are (1) to envisage a risk assessment plan for nonphospholipid-based topical ophthalmic emulsions with...

    Syed Nazrin Ruhina Rahman, Datta Maroti Pawde, ... Tamilvanan Shunmugaperumal in AAPS PharmSciTech
    Article 26 December 2019
  11. Ultraflexible lipid vesicles allow topical absorption of cyclosporin A

    Psoriasis and atopic dermatitis are widespread pathologies with a need to improve their treatment. Topical administration of cyclosporine A (CyA)...

    Juan J Carreras, Willian E Tapia-Ramirez, ... Ana Melero in Drug Delivery and Translational Research
    Article 06 December 2019
  12. Effect of P-glycoprotein Inhibition on the Penetration of Ceftriaxone Across the Blood–Brain Barrier

    Recent studies indicate that inhibition of the efflux transporter P-glycoprotein (P-gp) at the blood–brain barrier (BBB) may represent a putative...

    Yuheng Shan, Yuying Cen, ... Shengyuan Yu in Neurochemical Research
    Article 25 October 2021
  13. Evaluation of in vitro antileishmanial efficacy of cyclosporin A and its non-immunosuppressive derivative, dihydrocyclosporin A

    Background

    New therapeutic drugs are urgently needed against visceral leishmaniasis because current drugs, such as pentavalent antimonials and...

    Zhi-Wan Zheng, Jiao Li, ... Jian-** Chen in Parasites & Vectors
    Article Open access 21 February 2020
  14. Calcineurin-dependent regulation of gap junction conductance and connexin phosphorylation in guinea pig left atrium

    Atrial fibrillation (AF) occurs from disordered atrial action potential conduction and is associated with reduced gap junction electrical conductance...

    R. I. Jabr, S. C. Salvage, ... C. H. Fry in Pflügers Archiv - European Journal of Physiology
    Article Open access 14 March 2023
  15. Evasion and Suppression of Immunity

    Pathogens must evade or suppress the host’s immune system to persist. Immune evasion refers to passive evasion and active suppression of immune...
    Michael G. Milgroom in Biology of Infectious Disease
    Chapter 2023
  16. Bioinformatics screening of colorectal-cancer causing molecular signatures through gene expression profiles to discover therapeutic targets and candidate agents

    Background

    Detection of appropriate receptor proteins and drug agents are equally important in the case of drug discovery and development for any...

    Md Abu Horaira, Md. Ariful Islam, ... Md. Nurul Haque Mollah in BMC Medical Genomics
    Article Open access 29 March 2023
  17. Mouse precision-cut liver slices as an ex vivo model to study drug-induced cholestasis

    Drugs are often withdrawn from the market due to the manifestation of drug-induced liver injury (DILI) in patients. Drug-induced cholestasis (DIC),...

    R. E. H. Karsten, N. J. W. Krijnen, ... P. Olinga in Archives of Toxicology
    Article Open access 16 June 2022
  18. In Vitro Evaluation of P-gp-Mediated Drug–Drug Interactions Using the RPTEC/TERT1 Human Renal Cell Model

    Background and Objectives

    In vitro evaluation of the P-glycoprotein (P-gp) inhibitory potential is an important issue when predicting clinically...

    Sonia Saib, Sophie Hodin, ... Xavier Delavenne in European Journal of Drug Metabolism and Pharmacokinetics
    Article 22 December 2021
  19. Macrophage lipid accumulation in the presence of immunosuppressive drugs mycophenolate mofetil and cyclosporin A

    Objective

    Mycophenolate (MPA) and cyclosporin A (CsA) are two immunosuppressive agents currently used for the treatment of autoimmune diseases....

    Iryna Voloshyna, Isaac Teboul, ... Allison B. Reiss in Inflammation Research
    Article 21 June 2019
  20. Proteasome inhibition protects blood–brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer’s disease model

    Background

    Loss of P-glycoprotein (P-gp) at the blood–brain barrier contributes to amyloid-β (Aβ) brain accumulation in Alzheimer’s disease (AD)....

    Milica Vulin, Yu Zhong, ... Anika M. S. Hartz in Fluids and Barriers of the CNS
    Article Open access 06 October 2023
Did you find what you were looking for? Share feedback.